BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03374254-completion@plaintrial.com
DTSTAMP:20261028T050520Z
DTSTART;VALUE=DATE:20230718
SUMMARY:Safety and Efficacy of Pembrolizumab (MK-3475) Plus Binimetinib Alo
 ne or Pembrolizumab Plus Chemotherapy With or Without Binimetinib in Metas
 tatic Colorectal Cancer (mCRC) Participants (MK-3475-651/KEYNOTE-651) — 
 estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT03374254
URL:https://plaintrial.com/trial/NCT03374254
END:VEVENT
END:VCALENDAR